We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A new report led by researchers at Imperial College London has found that reducing antibiotic prescribing in primary care may not be enough alone to halt the rise in drug resistant Escherichia coli (E. Coli) infections in England.
Delivering the vaccine to the respiratory tract may be a good approach to inducing immune responses in the best place to enable a rapid response after exposure to airborne virus, say researchers.
Researchers at Imperial and Bayer Pharmaceuticals are partnering up to explore how artificial intelligence (AI) can be used to accelerate the discovery of new drugs for heart conditions.